British Institute of Radiology (BIR) U.K. MRI Course

Oct 7th, 2013Oct 10th, 2013
Birmingham, A7
GB
https://membersarea.bir.org.uk/multievents/layout1.asp
Phone:020 3668 2226
A four-day modular course covering MR physics, neuroradiology, body, and musculoskeletal imaging.
Latest in Home
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
CEM on par with MRI for breast cancer diagnosis, local staging
July 10, 2026
Cancer Target
New PET tracer show promise in neuroblastoma
July 9, 2026
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
The cost of AI, and finding its breakeven point
July 9, 2026
Experts at the Royal College of Radiologists’ 2nd Annual Global AI Conference discussed how AI could help move cancer care toward more personalized treatment, from targeted radionuclide therapy dosing to drug discovery.
AI aims to decode targeted radiotherapy response
July 8, 2026
More in Home
CEM on par with MRI for breast cancer diagnosis, local staging
By Amerigo Allegretto
CEM alone in a prospective study achieved perfect sensitivity and negative predictive value in diagnosing breast cancer.
July 10, 2026
MRI false positive for additional disease, (top to bottom): A. Index lesion—grade 2 invasive ductal carcinoma; B. MRI lesion two, upper inner quadrant: Stromal sclerosis and columnar cell change; C. MRI lesion three, upper outer quadrant: No ultrasound correlate, no malignancy on follow-up; D. CEM marked background parenchymal enhancement with a unifocal retroareolar lesion demonstrating wash-out on delayed MLO. Images are republished under a Creative Commons license (CC BY 4.0).
New PET tracer show promise in neuroblastoma
By Will Morton
F-18 mFBG achieved a pooled sensitivity of 97%, compared with 82% for I-123 MIBG.
July 9, 2026
Cancer Target
The cost of AI, and finding its breakeven point
By Claudia Tschabuschnig
Who pays, what, where, and when: speakers at the Royal College of Radiologists' Global AI Conference dug into what AI actually costs and when, if ever, it pays for itself.
July 9, 2026
Who's paying, and for what, is the question that actually decides whether AI in healthcare gets funded.
AI aims to decode targeted radiotherapy response
By Claudia Tschabuschnig
Same administered activity, different results. Speakers at the Royal College of Radiologists’ 2nd Annual Global AI Conference argued AI could help move targeted radionuclide therapy beyond a one-size-fits-all approach toward more precise, personalized treatment.
July 8, 2026
Experts at the Royal College of Radiologists’ 2nd Annual Global AI Conference discussed how AI could help move cancer care toward more personalized treatment, from targeted radionuclide therapy dosing to drug discovery.
RCR: Agentic AI is off the leash, and already a workhorse for health systems
By Claudia Tschabuschnig
The technical crowd took the stage at the 2nd Annual Global AI Conference in London last week, to show radiologists where agentic AI is running, how it operates across a spread of autonomy, and why only the highest tiers demand serious governance.
July 7, 2026
Dr. Rowland Illing, chief medical officer at Amazon Web Services (AWS) and a former interventional radiologist.
99% wasn't enough: How persistence in imaging changes the picture
By Claudia Tschabuschnig
Two patient stories told at the European Parliament proved that a second look can change everything.
July 6, 2026
European Parliament, Brussels. Policymakers, clinicians, and patient representatives at the 'Imaging Saves Lives' event, July 2.
PET/MRI can reduce the need for biopsies in prostate cancer
By Will Morton
Prostate biopsies are associated with considerable morbidity, including pain, rectal bleeding, prostatitis, and urinary tract infections.
July 2, 2026
A visual abstract of the study.
Imaging takes center stage in Europe's Safe Hearts Plan
By Claudia Tschabuschnig
Radiology and nuclear medicine are poised to play a central role in implementing the European Commission's Safe Hearts Plan, speakers said during a joint ESR/EANM event in Brussels.
July 2, 2026
The Safe Hearts Plan aims to shift healthcare systems toward prevention, earlier diagnosis, and more personalized care.
Can side-chain chemistry help radiologists choose a safer contrast agent after a hypersensitivity reaction?
By Claudia Tschabuschnig
Choosing an alternative contrast agent after an allergic reaction often falls to clinical judgment. A new review examines whether side-chain chemistry can make that decision a little more evidence based.
July 1, 2026
Dr. Aart J. van der Molen, of Leiden University Medical Center in Leiden, the Netherlands, is the lead author of a review exploring side-chain chemistry as a guide for selecting alternative iodine-based contrast media.
Most patients want to know if AI being used for imaging reports
By Amerigo Allegretto
Most patients want disclosure about whether AI is being used for their imaging reports.
June 30, 2026
Patient Cancer Doctor 400 (1)
Low muscle density on coronary CT linked to heart risk
By Will Morton
Patients with skeletal muscle attenuation below the median had a higher risk of mortality and myocardial infarction.
June 30, 2026
An example of machine learning–based multiorgan body composition assessment (TotalSegmentator V2.0.4, 1.5-mm high-resolution model) in a 63-year-old man with obstructive coronary artery disease and a skeletal muscle attenuation below the median. (A) Transverse, (B) coronal, and (C) sagittal CT images and curved planar reformations of the (D) left, (E) circumflex, and (F) right coronary arteries.
More work than relief: AI in the wrong seat, RCR census finds
By Claudia Tschabuschnig
AI adoption is climbing fast across U.K. radiology and cancer services, but put in the wrong room, it creates more noise than signal.
June 29, 2026
AI adoption is growing across UK imaging and cancer services, but workforce shortages persist-
Page 1 of 87
Next Page